Modulating SARS-CoV‑2 Spike Protein Reactivity through Moderate Electric Fields: A Pathway to Innovative Therapies

Ähnliche Einträge

• Modulating SARS-CoV‑2 Spike Protein Reactivity through Moderate Electric Fields: A Pathway to Innovative Therapies
  von: Thi-Huong Nguyen, et al.
  Veröffentlicht: (2023-11-01)
• Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
  von: Tomoyuki Homma, et al.
  Veröffentlicht: (2024-01-01)
• Author Correction: No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations
  von: Jenna M. Benoit, et al.
  Veröffentlicht: (2025-06-01)
• In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants
  von: Muhammad Haseeb, et al.
  Veröffentlicht: (2023-03-01)
• Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV‑2 Infection”
  von: Soledad Stagnoli, et al.
  Veröffentlicht: (2024-01-01)